Ceftazidime Usage in Elderly

## Ceftazidime Dosing in an 86-Year-Old Male with Elevated Creatinine ### Renal Function Estimation For an 86-year-old male, the serum creatinine of 140 μmol/L (approximately 1.58 mg/dL) requires conversion to estimate creatinine clearance (CrCl) using the Cockcroft-Gault equation, as specified in the retrieved prescribing information[3]: **CrCl (mL/min) = [Weight (kg) × (140 - age)] / [72 × serum creatinine (mg/dL)]** Assuming a typical body weight (e.g., 70 kg): - CrCl = [70 × (140 - 86)] / [72 × 1.58] - CrCl = [70 × 54] / [113.76] - CrCl = 3780 / 113.76 ≈ **33.2 mL/min** This places the patient in the **moderate renal impairment** category (CrCl 30–50 mL/min) per the ceftazidime label[1][3]. ### Recommended Dosing Regimen Based on the retrieved drug labels, the following dosing applies for CrCl 31–50 mL/min[3]: | Parameter | Recommendation | |-----------|---------------| | **Loading dose** | 1 g IV (if not already administered) | | **Maintenance dose** | 1 g every 12 hours | | **Route** | IV | | **Special note** | If the infection is severe and the patient would normally receive 2 g every 8 hours, the unit dose may be increased by 50% or frequency adjusted, guided by therapeutic monitoring[1][3] | ### Key Safety Considerations - **Geriatric population**: This patient is ≥65 years old. The "start low, go slow" principle is inherently addressed by the renal-adjusted dosing above. Monitor for neurotoxicity (seizures, encephalopathy) which is more common in elderly patients with renal impairment receiving cephalosporins. - **Renal function monitoring**: CrCl should be calculated using actual body weight. If the patient's weight differs significantly from the 70 kg assumption, recalculate accordingly. - **DUPLEX® container restriction**: The 1 g or 2 g premixed formulation should **not** be used in patients with CrCl ≤15 mL/min who require less than a 1 g dose[1]. This patient's estimated CrCl (~33 mL/min) is above this threshold, so the formulation is appropriate. - **Hemodialysis**: If the patient requires hemodialysis, administer a 1 g loading dose followed by 1 g after each dialysis session[1][3]. ### Hepatic Function No dosage adjustment is required for hepatic dysfunction[2]. --- ### Further Diagnostic Suggestions (Reference Only) To enable a more accurate assessment, if available, please consider providing: - **Patient's actual body weight**: Required for precise Cockcroft-Gault calculation; the current estimate assumes 70 kg. - **Infection severity and site**: Determines whether the standard 1 g q12h regimen is sufficient or if a higher dose (e.g., 2 g q12h or 1 g q8h) is warranted per the label's severe infection provision. --- *This analysis is based on retrieved prescribing information for ceftazidime. Always verify against the official drug label and individual patient parameters before prescribing.*